Farm animal drugs market to hit $28.88 billion by 2030

By AI, Created 11:18 AM UTC, May 20, 2026, /AGP/ – The global farm animal drugs market is projected to grow from $21.96 billion in 2026 to $28.88 billion by 2030, driven by rising meat consumption, tighter food safety rules and antimicrobial stewardship. Asia-Pacific held the largest share in 2025 and is expected to remain the fastest-growing region.

Why it matters: - Farm animal drugs support livestock health, productivity and disease prevention in cattle, pigs and poultry. - The market is tied to food security because healthier herds and flocks help maintain supply of animal-derived food products. - Rising regulation around food safety, animal welfare and antimicrobial use is pushing demand toward safer and more targeted veterinary treatments.

What happened: - The Business Research Company released its Farm Animal Drugs Global Market Report 2026, covering market size, trends and forecasts through 2030. - The report places the market at $20.66 billion in 2025 and $21.96 billion in 2026, a 6.3% compound annual growth rate. - The market is forecast to reach $28.88 billion by 2030, growing at a 7.1% CAGR. - Asia-Pacific held the largest share of the market in 2025. - The report also covers South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company published links to a free sample report and the full market report.

The details: - Farm animal drugs are used to treat, prevent and manage disease in livestock. - The category covers medications for disease control in commercial farming operations and veterinary care. - Historical growth has been supported by a larger global livestock population, more infectious disease pressure, higher meat demand and wider commercial farming. - Future growth is expected from antimicrobial stewardship efforts, premium animal protein demand, veterinary healthcare infrastructure, stricter food safety and animal welfare rules, and livestock-specific drug innovation. - The report says rising meat consumption is a major market driver. - UK meat production reached 4,166 thousand tonnes in 2024, up from 4,059 thousand tonnes in 2023, according to Defra in July 2025. - The report says this rise in production reflects stronger demand for veterinary drugs. - Tighter standards on drug residues and animal welfare are encouraging combination therapies and preventive treatments tailored to intensive farming.

Between the lines: - The market outlook points to a shift from broad disease treatment toward prevention, compliance and formulation precision. - Asia-Pacific’s lead suggests livestock expansion and healthcare investment are concentrating growth outside mature Western markets. - The emphasis on stewardship shows the sector is growing under more scrutiny, not less, which could favor companies with stronger regulatory and safety profiles.

What’s next: - The market is expected to keep expanding through 2030 as meat demand, livestock production and veterinary standards rise. - Regulatory pressure should continue to shape product development, especially for antimicrobial alternatives and combination drugs. - The report positions Asia-Pacific as the main growth engine over the forecast period. - The Business Research Company also listed related reports on animal medicine, animal drug compounding and farm animal healthcare.